Am J Transplant, Volume 19, Suppl 3 Archives - Page 133 of 214 - ATC Abstracts

2019 American Transplant Congress
Impact of Delayed Graft Function on Allograft Survival in DCD versus DBD Kidneys
T. Ishaque, A. B. Massie, J. Ruck, C. Holscher, J. G. Wang, D. L. Segev
Surgery, Johns Hopkins School of Medicine, Baltimore, MD
*Purpose: Several single-center studies have suggested no link between delayed graft function (DGF) and graft survival in recipients of donation after cardiac death (DCD) kidneys,…
2019 American Transplant Congress
Assessment of Health-Related Quality of Life and Graft Failure among Kidney Transplant Patients in the Benefit and Benefit-EXT Trials
I. Purnajo¹, J. L. Beaumont¹, M. Polinsky², E. Alemao², M. J. Everly¹
¹Terasaki Research Institute, Los Angeles, CA, ²Bristol Myers Squibb, Princeton, NJ
*Purpose: To achieve patient focused drug development in renal transplant, we need to better understand how the patient’s perspective of health-related quality of life (HRQoL)…
2019 American Transplant Congress
Self-reported Marijuana Use In Kidney Transplant Candidates And Its Association With Access To Transplantation
S. Rodriguez Ramirez, E. Tang, O. Famure, A. Bansal, J. Kim, I. Mucsi
Kidney Transplant, Toronto General Hospital, Toronto, ON, Canada
*Purpose: In light of the current legislative changes in Canada, and the variable approach to marijuana use in the United States, it is important to…
2019 American Transplant Congress
Diagnostic Efficacy of Color Doppler Ultrasound on Recipients with Transplanted Renal Artery Stenosis: A Single Center Experience
Y. Yang, Z. Wang, S. Fei, H. Chen, L. Sun, Z. Han, J. Tao, X. Ju, R. Tao, M. Gu
No.300 Guangzhou Road of Nanjing, Nanjing, China
*Purpose: Our study was to explore the diagnostic efficacy of Color Doppler ultrasound (CDUS) on the diagnosis of allogeneic transplanted renal artery stenosis (TRAS) during…
2019 American Transplant Congress
The Molecular Pathology of Immune Checkpoint Inhibitor-Associated Renal Allograft Rejection: Overlap with Acute Interstitial Nephritis
B. Adam¹, C. Boils², L. Bu³, K. Renaudin⁴, K. Wen¹, M. Mengel¹
¹University of Alberta, Edmonton, AB, Canada, ²Arkana Labs, Little Rock, AR, ³University of Minnesota, Minneapolis, MN, ⁴CHU Nantes, Nantes, France
*Purpose: The use of immune checkpoint inhibitors (ICIs) for various malignancies has been associated with numerous immunological adverse events, including acute interstitial nephritis (AIN) in…
2019 American Transplant Congress
Comparison of Long-Term Outcomes between Alemtuzumab and Rabbit Anti-Thymocyte Globulin for Acute Kidney Allograft Rejection
M. van der Zwan, M. C. Clahsen-van Groningen, D. L. Roelen, M. W. van den Hoogen, M. Van Agteren, J. I. Roodnat, C. C. Baan, D. A. Hesselink
Erasmus MC, Rotterdam, Netherlands
*Purpose: T cell-depleting antibody therapy with rabbit anti-thymocyte globulin (rATG) is the treatment of choice for glucocorticoid-resistant, recurrent and/or severe acute kidney allograft rejection (AR).…
2019 American Transplant Congress
Renal Function, Albuminuria, and the Risk of Hemorrhage and Thrombosis after Kidney Transplantation
N. N. Lam¹, P. Ravani², R. R. Quinn², M. Tonelli², F. Ye¹, B. R. Hemmelgarn², M. M. Sood³
¹University of Alberta, Edmonton, AB, Canada, ²University of Calgary, Calgary, AB, Canada, ³University of Ottawa, Ottawa, ON, Canada
*Purpose: Compared to the general population, kidney transplant recipients are at increased risk of hemorrhage and thrombosis. Whether this risk is affected by kidney function…
2019 American Transplant Congress
Successful Kidney Transplant Improves Glucose Tolerance – A Paradoxical Report From A Single Center
A. Mitsuke, H. Harada, H. Higuchi, N. Fukuzawa, H. Tanaka, T. Hirano, T. Sekii
Kidney Transplantation Surgery, Sapporo City General Hospital, Sapporo, Japan
*Purpose: Kidney recipients tend to impair glucose tolerance because of several factors such as post-operative obesity, and chronic exposure of some diabetogenic immunosuppressants like calcineurin…
2019 American Transplant Congress
Antihypertensive Medication Requirements with Native Nephrectomy and Kidney Transplantation
J. Buggs¹, J. Sykes², S. Lloyd², E. Rogers¹, L. Wang³, J. Wei³, J. Zhang³, A. Kumar³, R. Liu³, V. Bowers¹
¹Tampa General Hospital, Tampa, FL, ²University of Florida, Gainesville, FL, ³University of South Florida, Tampa, FL
*Purpose: The literature suggests a more significant persistence of hypertension following kidney transplantation alone than with kidney transplantation and native nephrectomy. This philosophy is in…
2019 American Transplant Congress
Efficacy and Safety of Everolimus in Pediatric Renal Transplantation
T. Sandes-Freitas¹, B. Pantoja², M. Custódio², A. Goersch Silva³, R. Costa², M. Sales³, R. Esmeraldo³
¹Hospital Geral de Fortaleza / Federal University of Ceara, Fortaleza, Brazil, ²Federal University of Ceará, Fortaleza, Brazil, ³Hospital Geral de Fortaleza, Fortaleza, Brazil
*Purpose: There are scarce evidence on the efficacy and safety of everolimus (EVR)-based regimens in pediatric kidney transplantation (KT).*Methods: This single center retrospective cohort analyzed…